Metraipolis › archive › dc_aad0797dc16a

Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors — Europe PMC PMID:41826558

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41826558
DOI
10.1007/s00280-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-04T09:35:35.525Z
SHA-256 of the archived text
588c37e0f8823a6c6121dcf13526096e35a2ed42422995ad5685bcf7ee157861
Stable URL of this page
https://metraipolis.com/documento/dc_aad0797dc16a

How to cite

Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors — Europe PMC PMID:41826558 — Europe PMC (en), https://europepmc.org/article/MED/41826558 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aad0797dc16a (Metraipolis archive dc_aad0797dc16a, sha256 588c37e0f8823a6c6121dcf13526096e35a2ed42422995ad5685bcf7ee157861)
BibTeX
@misc{dcaad0797dc16a,
  title = {Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors — Europe PMC PMID:41826558},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41826558},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aad0797dc16a; sha256 588c37e0f8823a6c6121dcf13526096e35a2ed42422995ad5685bcf7ee157861},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41826558. Agents can read the archived copy with the MCP tool read_document.